🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523846-29-00
Completed Phase I

A clinical trial investigating the safety and biological activity of the antibody BNT351 in adults living without and with HIV

2025-523846-29-00 · tracked via the Priya Life Science EU tracker
Sponsor
BioNTech SE
Sponsor type
Pharmaceutical company
Therapeutic area
Virus Diseases
Decision date
22/12/2025
Enrollment target
50
Sites
Germany

Condition studied

HIV-1 infection

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523846-29-00 on CTIS ↗ ← All trials in the EU